Share on StockTwits

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced its earnings results on Thursday. The company reported $0.07 EPS for the quarter, AmericanBankingNews.com reports.

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) traded down 3.60% during mid-day trading on Thursday, hitting $5.35. 19,325 shares of the company’s stock traded hands. Nymox Pharmaceutical Corporation has a 52-week low of $4.40 and a 52-week high of $8.19. The stock has a 50-day moving average of $5.27 and a 200-day moving average of $5.94. The company’s market cap is $186.5 million.

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is a biopharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.